Cannabis Patents and Trademarks

Sterne Kessler brings a full range of IP capabilities to innovators in the emerging cannabis industry – from patents to brand protection.

Therapies and consumer products that include cannabis-derived compounds, such as cannabidiol, recently spurred the U.S. Food and Drug Administration to hold its first public hearing on cannabis regulation in 2019. The 2018 Farm Bill declassified hemp as a controlled substance, creating new business opportunities in the hemp and hemp-derived product space.

The business and regulatory landscape for cannabis is dynamic and evolving. Cannabis patent portfolios have been at the center of several acquisitions and cannabis is quickly becoming an industry where cutting-edge biotechnology, informatics, and branding are driving competition and valuation. The race for cannabis intellectual property is already underway and is likely to intensify as the regulatory landscape matures and federally-approved pathways are defined.

Sterne Kessler’s deep experience in developing patent portfolios, trademarks, and trade dress protection in the areas of pharmaceuticals, biotechnology,
medical devices, consumer products, industrial products, food science and packaging, software, agricultural technology, and animal health positions the firm well to assist innovators in the cannabis industry as they develop and protect IP related to their inventions, products, and brands. The firm helps innovators of all sizes and stages – from leading global pharmaceutical companies to start-ups. Regardless of size and stage of development, Sterne Kessler’s IP professionals can help you develop robust and defensible patent and trademark portfolios that create substantial shareholder value.

Our services for cannabis companies run the full spectrum of intellectual property.

  • We prepare and prosecute patent applications before the U.S. and foreign patent offices.
  • Similarly, we prepare and prosecute trademarks domestically and internationally.
    • It is important to note, however, that the U.S. Patent & Trademark Office has generally refused to register trademarks on products and services that lack a “legal use” of the mark in commerce. As a result, there currently are limitations on the availability of trademark protection for cannabis brands and you should consult with a trademark attorney about eligibility.
    • Copyright registration for logos and other marketing materials may be a reasonable way to protect brand-related materials and Sterne Kessler can help with registration as well.
  • When patent validity is in question, we take the lead on patent office litigation in post-grant proceedings before the Patent Trial and Appeal Board (“PTAB”).
  • When disputes arise related to patent or trade secret infringement we lead litigation in court as well as before the U.S. International Trade Commission (“ITC”).
  • When disputes center on trademarks, trade dress, or other aspects of brand protection, we lead litigation in appropriate venues – including anti-counterfeiting campaigns.
  • For those collaborating, licensing or commercializing innovations, we provide counseling regarding agreements and can provide freedom to operate opinions.
  • Additionally, we conduct intellectual property due diligence to support our clients who are investing in promising new technologies or making acquisitions.

Disclaimer: Please be mindful that possessing, using, distributing, and selling marijuana are considered federal crimes. The content provided here is not intended to provide legal advice or suggest that marijuana and marijuana use are currently legal under federal law.

Related Resources

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox May 31, 2023

MarkIt to Market®

MarkIt to Market® – May 2023

May 31, 2023

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox January 30, 2023

MarkIt to Market®

MarkIt to Market® – January 2023

January 30, 2023

In the News

A Hazy Picture: The State of Play for Cannabis IP in 2023

Managing IP January 18, 2023

Bylined Articles

Priority Pitfalls

Sterne, Kessler, Goldstein & Fox November 30, 2022

MarkIt to Market®

MarkIt to Market® – November 2022

November 30, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox September 30, 2022

MarkIt to Market®

MarkIt to Market® – September 2022

September 30, 2022

MarkIt to Market®

MarkIt to Market® – May 2022

May 26, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox May 26, 2022

MarkIt to Market®

MarkIt to Market® – April 2022

April 28, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox April 28, 2022

MarkIt to Market®

MarkIt to Market® – March 2022

March 30, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox March 30, 2022

MarkIt to Market®

MarkIt to Market® – February 2022

February 25, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox February 25, 2022

MarkIt to Market®

MarkIt to Market® – January 2022

January 28, 2022

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox January 28, 2022

In the News

New Process to Nix Unused Trademarks Leads 2022 USPTO Priorities

Bloomberg Law December 30, 2021

MarkIt to Market®

MarkIt to Market® – December 2021

December 22, 2021

Bylined Articles

Thoroughly Modern! The Trademark Modernization Act Offers New Tools for Trademark Owners

Sterne, Kessler, Goldstein & Fox December 22, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox December 22, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox December 22, 2021

MarkIt to Market®

MarkIt to Market® – November 2021

November 30, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox November 30, 2021

Press Release

Director Monica Riva Talley Earns Lexology Client Choice Award for Excellence in Client Service

Sterne, Kessler, Goldstein & Fox October 27, 2021

MarkIt to Market®

MarkIt to Market® – October 2021

October 26, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox October 26, 2021

MarkIt to Market®

MarkIt to Market® – September 2021

September 30, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox September 30, 2021

Bylined Articles

Trailblazing Cannabis Legislation Updates

Sterne, Kessler, Goldstein & Fox September 30, 2021

MarkIt to Market®

MarkIt to Market® – August 2021

August 27, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox August 27, 2021

MarkIt to Market®

MarkIt to Market® – July 2021

July 26, 2021

Bylined Articles

Budding Legislation – The Cannabis Administration and Opportunity Act

Sterne, Kessler, Goldstein & Fox July 26, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox July 26, 2021

MarkIt to Market®

MarkIt to Market® – June 2021

June 25, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox June 25, 2021

MarkIt to Market®

MarkIt to Market® – May 2021

May 27, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox May 27, 2021

MarkIt to Market®

MarkIt to Market® – April 2021

April 29, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox April 29, 2021

In the News

Intellectual Property Takes on Growing Role in Cannabis Industry Deals

Marijuana Business Daily April 5, 2021

MarkIt to Market®

MarkIt to Market® – March 2021

March 31, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 31, 2021

Bylined Articles

H.R. 841 – Federal CBD Deregulation Bill Back in Play

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 31, 2021

Bylined Articles

GW Pharma Seeks Dismissal of Patent Suit Filed in Texas by Canopy Growth

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 31, 2021

MarkIt to Market®

MarkIt to Market® – February 2021

February 25, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox February 25, 2021

MarkIt to Market®

MarkIt to Market® – January 2021

January 28, 2021

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox P.L.L.C. January 28, 2021

MarkIt to Market®

MarkIt to Market® – December 2020

December 22, 2020

Bylined Articles

Watching the Pot™

Sterne, Kessler, Goldstein & Fox P.L.L.C. December 22, 2020

Speaking Engagement

Protecting Cannabis Intellectual Property

November 16, 2020 12:30 PM - 2:00 PM PST

Press Release

Sterne Kessler Named Among 2021 “Best Law Firms” by Best Lawyers

Sterne, Kessler, Goldstein & Fox November 6, 2020

Speaking Engagement

Special Topics in Cannabis: Genetics & Bioscience

October 29, 2020 3:30 PM - 4:30 PM PST

MarkIt to Market®

MarkIt to Market® – October 2020

October 28, 2020

Bylined Articles

Get in the Weeds: Even Brands for (Federally Illegal) Consumables Need to Play by the Trademark Rules

Sterne, Kessler, Goldstein & Fox P.L.L.C. October 28, 2020

MarkIt to Market®

MarkIt to Market® – September 2020

September 30, 2020

Bylined Articles

CB – Don’ts

Sterne, Kessler, Goldstein & Fox P.L.L.C. September 30, 2020

MarkIt to Market®

MarkIt to Market® – June 2020

June 30, 2020

Bylined Articles

CBD Ingredient Brands – Trademark Registration Is Possible, but May Be a Tough Pill to Swallow

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 30, 2020

In the News

Black IP lawyers reveal struggles with systemic racism

Managing IP June 15, 2020

Bylined Articles

Patent Demand Lessons For Cannabis Cos. From Big Tech

Law360 March 11, 2020

In the News

Cannabis Companies Reveal Trade Secret Conundrums

Managing Intellectual Property February 28, 2020

Webinar

Protecting Cannabis IP: Patents, Trademarks, Copyrights, and Trade Secrets

December 13, 2019 1:00 PM - 2:30 PM PST

In the News

EU Court Decision Says Cannabis Products Cannot Be Granted Trademarks

Cannabis Law Review December 12, 2019

MarkIt to Market®

MarkIt to Market® – November 2019

November 27, 2019

Bylined Articles

USDA’s New Hemp Rules are a Step Towards Federal Trademark Registration

Sterne, Kessler, Goldstein & Fox P.L.L.C November 27, 2019

Bylined Articles

Assessing USDA Hemp Rule’s Impact On Cannabis IP

Law360 November 1, 2019

MarkIt to Market®

MarkIt to Market® – October 2019

October 31, 2019

Bylined Articles

Waiting to Exhale – Clarity Around Enforcement of Trademarks for Cannabis Goods is a Pipe Dream

Sterne, Kessler, Goldstein & Fox P.L.L.C October 31, 2019

Bylined Articles

Hot Off the Press: USDA Issues Interim Rules for Legal Hemp Cultivation

Sterne, Kessler, Goldstein & Fox P.L.L.C October 31, 2019

In the News

Cannabis Patent Activity Surges Amid Industry Gold Rush

Law360 October 16, 2019

In the News

Cannabis Companies Gamble on Patents to Lure Possible Suitors

Bloomberg Law August 1, 2019

MarkIt to Market®

MarkIt to Market® – July 2019

July 31, 2019

Global Patent Prosecution

Global Patent Prosecution Newsletter – June 2019

June 12, 2019

Bylined Articles

Cannabis Patenting at an All-Time High Despite Illegal Status

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 12, 2019

Bylined Articles

Hemp Legalization and the International CBD Boom

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 12, 2019

Bylined Articles

A Useful Roadmap for Claiming Cannabis Inventions

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 12, 2019

Bylined Articles

IP’s Developing Role In Cannabis Business Strategy

Law360 June 11, 2019

MarkIt to Market®

MarkIt to Market® – April 2019

April 30, 2019

Bylined Articles

Are Cosmetic Products Containing Hemp-Derived CBD On a Faster Track To Being Lawful?

Sterne, Kessler, Goldstein & Fox P.L.L.C. April 30, 2019

Bylined Articles

What’s the Answer: Does the 2018 Farm Bill Create a Path for Federal Trademark Registration of CBD Products?

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 29, 2019

MarkIt to Market®

MarkIt to Market® – February 2019

March 1, 2019

Bylined Articles

Up in Smoke? IP Protection for Cannabis Products

Sterne, Kessler, Goldstein & Fox P.L.L.C. March 1, 2019

PTAB Strategies and Insights

PTAB Strategies and Insights – January 2019

January 24, 2019

Bylined Articles

PTAB Only Partially Smokes Cannabis Patent

Sterne, Kessler, Goldstein & Fox P.L.L.C. January 24, 2019

Bylined Articles

What Cannabis Patent Applicants Can Learn From Biopharma

Law360 January 17, 2019

In the News

3 Takeaways From The PTAB’s Cannabis Experience

Law360 January 11, 2019